Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Assets (2016 - 2025)

Historic Return on Assets for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to 0.63%.

  • Rocket Pharmaceuticals' Return on Assets rose 100.0% to 0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.49% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, Rocket Pharmaceuticals' Return on Assets stood at 0.63%, which was up 100.0% from 0.59% recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Return on Assets high stood at 0.26% for Q1 2021, and its period low was 0.64% during Q3 2024.
  • In the last 5 years, Rocket Pharmaceuticals' Return on Assets had a median value of 0.47% in 2022 and averaged 0.47%.
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Return on Assets surged by 200bps in 2023, and later crashed by -1500bps in 2024.
  • Rocket Pharmaceuticals' Return on Assets (Quarter) stood at 0.33% in 2021, then tumbled by -41bps to 0.46% in 2022, then rose by 4bps to 0.44% in 2023, then tumbled by -32bps to 0.58% in 2024, then dropped by -9bps to 0.63% in 2025.
  • Its Return on Assets was 0.63% in Q3 2025, compared to 0.59% in Q2 2025 and 0.53% in Q1 2025.